Bayesian Capital Management’s Nikola Corporation Common Stock NKLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-16,560
Closed -$517K – 1161
2024
Q1
$517K Buy
16,560
+11,167
+207% +$240K 0.05% 426
2023
Q4
$142K Buy
+5,393
New +$168K 0.02% 640
2023
Q2
– Sell
-1,650
Closed -$59.9K – 1113
2023
Q1
$59.9K Buy
+1,650
New +$108K 0.01% 709
2022
Q3
– Sell
-3,330
Closed -$476K – 1071
2022
Q2
$476K Buy
+3,330
New +$681K 0.09% 349
2022
Q1
– Sell
-2,196
Closed -$650K – 956
2021
Q4
$650K Buy
+2,196
New +$733K 0.21% 145
2021
Q2
– Sell
-1,327
Closed -$553K – 691
2021
Q1
$553K Buy
1,327
+667
+101% +$380K 0.13% 210
2020
Q4
$302K Sell
660
-4,989
-88% -$3.11M 0.08% 302
2020
Q3
$3.47M Buy
+5,649
New +$6.58M 0.85% 13

Other funds holding NKLA

Bayesian Capital Management's NKLA Position: Q2 2024 in Review

Bayesian Capital Management sold out of Nikola Corporation Common Stock (NKLA) in Q2 2024, closing a stake of 16,560 shares — an estimated $517K sold.

Bayesian Capital Management first reported a position in NKLA in Q3 2020 and held it in 8 quarters. The position peaked at $3.47M in Q3 2020. 159 funds tracked by Wall St. Rank hold NKLA as of Q2 2024.

  • Bayesian Capital Management reported no remaining Nikola Corporation Common Stock position as of Q2 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 16,560 Nikola Corporation Common Stock shares in Q2 2024, an estimated $517K.
  • Bayesian Capital Management first reported a position in Nikola Corporation Common Stock in Q3 2020 and held it in 8 quarters.
  • Bayesian Capital Management's Nikola Corporation Common Stock position peaked at $3.47M in Q3 2020.
  • 159 funds tracked by Wall St. Rank held Nikola Corporation Common Stock as of Q2 2024.

Based on Bayesian Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.